Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Mycobacteriology"
DOI: 10.4103/ijmy.ijmy_178_22
Abstract: Background: A regimen containing bedaquiline–delamanid is recommended in management of drug-resistant tuberculosis (DR TB) to increase a success rate. However, this regimen was rare in a clinical setting due to a potential risk of QT… read more here.
Keywords: review; regimen containing; bedaquiline delamanid; prolongation ... See more keywords